Farglitazar
id:
farglitazar-252-18116378
title:
Farglitazar
text:
Farglitazar is a peroxisome proliferator-activated receptor agonist which was formerly under development by GlaxoSmithKline, but has never been marketed. It progressed to phase II clinical trials for the treatment of hepatic fibrosis, but failed to show efficacy. After reaching phase III for type 2 diabetes, further development was discontinued.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Farglitazar
date created:
date modified:
2023-12-20T21:38:40Z
main entity:
{"identifier":"Q5435087","url":"https://www.wikidata.org/entity/Q5435087"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/1e/Farglitazar.svg","width":512,"height":212}
fields total:
13
integrity:
15